Skip to main content
Fig. 8 | Molecular Neurodegeneration

Fig. 8

From: Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay

Fig. 8

Summarised Venn diagram of the targeted proteomics analysis of the multicentre cohort 2 (AD, LBD, PD and controls). The majority of markers are dementia specific (common to both LBD and AD). However, although there are no markers specific to LBD, the proteins ENPP2, transthyretin, pro-orexin and LAMP1 were specific for the AD group. Three markers were elevated in all groups and Protein DJ was specific to PD. Markers in bold are those discovered in the proteomic profiling experiment. Those with an * are novel markers not previously described

Back to article page